Manufacturers have no sight of draft questions and no opportunity to engage with assessors during the scoping phase
Final scoping is likely to include numerous PICOs with no cap on the consolidated final number. This could lead to unmanageable workloads for manufacturers if using traditional evidence generation/evidence synthesis methods
Only 100 days from receiving finalised JCA scope to develop the dossier and all required evidence for multiple PICOs
Comprehensive understanding of Health Technology Assessment (HTA) and a dedicated focus on aligning with evolving European Network for Health Technology Assessment (EUnetHTA) standards.
Utilising our team’s extensive experience in conducting HTAs and adhering to procedural templates and legislation uniquely positions us to excel in this area.
Vigilant in staying current with changes and regulations, ensuring we are well-prepared to undertake JCA projects effectively and successfully.
Complete pre-scoping work and managing ad-hoc JCA clinical requests at the country level and subsequent HTA submissions
.png){kind=small}
